thiodigalactoside has been researched along with Pulmonary Fibrosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blanchard, H; Collins, P; Leffler, H; MacKinnon, A; Mandal, S; Mukhopadhyay, B; Nilsson, UJ; Rajput, VK; Schambye, H; Sethi, T | 1 |
1 other study(ies) available for thiodigalactoside and Pulmonary Fibrosis
Article | Year |
---|---|
A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model.
Topics: Animals; Bleomycin; Coumarins; Galactosides; Galectin 3; Humans; Mice; Models, Molecular; Mutation; Polysaccharides; Protein Binding; Pulmonary Fibrosis; Structure-Activity Relationship; Thiogalactosides | 2016 |